Degradation of pharmaceuticals from membrane biological reactor sludge with Trametes versicolor
dc.contributor.author
dc.date.accessioned
2016-07-22T11:01:39Z
dc.date.available
2016-07-22T11:01:39Z
dc.date.issued
2015-02-01
dc.identifier.issn
2050-7887
dc.identifier.uri
dc.description.abstract
Emerging contaminants are a wide group of chemical products that are found at low concentrations in the environment. These contaminants can be either natural, e.g., estrogens, or synthetics, such as pesticides and pharmaceuticals, which can enter the environment through the water and sludge from wastewater treatment plants (WWTP). The growth of Trametes versicolor on membrane biological reactor (MBR) sludge in bioslurry systems at the Erlenmeyer scale was assessed and its capacity for removing pharmaceutical and personal care products (PPCPs) was evaluated. The ability of the fungus to remove hydrochlorothiazide (HZT) from liquid media cultures was initially assessed. Consequently, different bioslurry media (complete nutrient, glucose and no-nutrient addition) and conditions (sterile and non-sterile) were tested, and the removal of spiked HZT was monitored under each condition. The highest spiked HZT removal was assessed under non-sterile conditions without nutrient addition (93.2%). Finally, the removal assessment of a broad set of pharmaceuticals was performed in non-spiked bioslurry. Under non-sterile conditions, the fungus was able to completely degrade 12 out of the 28 drugs initially detected in the MBR sludge, achieving an overall degradation of 66.9%. Subsequent microbial analysis showed that the microbial diversity increased after 15 days of treatment, but there was still some T. versicolor in the bioslurry. Results showed that T. versicolor can be used to remove PPCPs in bioslurry systems under non-sterile conditions, without extra nutrients in the media, and in matrices as complex as an MBR sludge
dc.description.sponsorship
This work has been supported by the Spanish Ministry of Economy and Competitiveness (projects CTQ2010-21776-C01 and CTQ2010-21776-C02), cofinanced by the European Union through the European Regional Development Fund (ERDF) and supported by the Generalitat de Catalunya (Consolidated Research Groups: Biodegradation of Industrial Pollutants and Waste Recovery Group -2009-SGR-656- and Catalan Institute for water Research – 2014 SGR 291)
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
Royal Society of Chemistry
dc.relation
info:eu-repo/grantAgreement/MICINN//CTQ2010-21776-C02-01/ES/TRATAMIENTO NO CONVENCIONAL DE DEGRADACION POR HONGOS DE FARMACOS EN EFLUENTES: DESARROLLO DE PROCESO, MONITORIZACION Y EVALUACION DEL RIESGO/
dc.relation.isformatof
Reproducció digital del document publicat a: http://dx.doi.org/10.1039/c4em00579a
dc.relation.ispartof
© Environmental Sciences: Processes and Impacts, 2015, vol. 17, p. 429-440
dc.relation.ispartofseries
Articles publicats (ICRA)
dc.rights
Tots els drets reservats
dc.subject
dc.title
Degradation of pharmaceuticals from membrane biological reactor sludge with Trametes versicolor
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/embargoedAccess
dc.embargo.terms
Cap
dc.date.embargoEndDate
info:eu-repo/date/embargoEnd/2026-01-01
dc.type.version
info:eu-repo/semantics/publishedVersion
dc.identifier.doi
dc.identifier.idgrec
022869
dc.contributor.funder
dc.relation.ProjectAcronym
dc.identifier.eissn
2050-7895